Lazard stock faces a sharp 21% decline over a nine-day losing streak, highlighting fundamental weaknesses compared to S&P 500 Financials peers and prompting investors to reconsider concentrated positions.
LAZ has fallen 21% over nine consecutive sessions, erasing about $938 million in market value, with revenue growth and operating margin trailing sector medians.
The S&P 500 is referenced as a benchmark, returning -0.9% over the same nine-day period.
XLF is mentioned as a diversified financials ETF alternative to holding LAZ directly.
Lazard (LAZ) shares have plummeted 21% over nine consecutive trading sessions, significantly underperforming the S&P 500. The sell-off has wiped $938 million from the firm's market capitalization, leaving the stock at $35.75 as fundamental metrics, including revenue growth and operating margins, continue to trail sector medians.
While the specific catalyst for the nine-day slide remains unclear, the stock's fundamentals appear weak relative to peers, with revenue growth and operating margins lagging behind S&P 500 Financials medians.